Keywords: Ophthotech, Frova, Wet AMD, Ph IIb, Lucentis

Ophthotech's Fovista tops Lucentis in wet AMD

Article | 15 June 2012

Privately-held US biotech firm Ophthotech Corp has announced results from the first clinical trial to show statistically significant superior efficacy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ophthotech

Go to company listing

Related Drugs

Lucentis

Fovista

Go to drug listing